BioHealth News Archive
The top pharma companies in social media | FiercePharma
Social media is no longer just a numbers game for pharma companies. Counting followers, tallying likes or tracking shares was a good start, but…
Read More
Emergent Biosolutions CEO: No ‘guarantee’ vaccine will be ready this year
Emergent Biosolutions CEO Robert Kramer told CNBC Monday it is uncertain that a coronavirus vaccine can be available by the end of the year to fulfill…
Read More
Immunomic Therapeutics Announces Appointments to its Board of Directors | Business & Finance | tullahomanews.com
ROCKVILLE, Md.--(BUSINESS WIRE)--May 5, 2020-- Immunomic Therapeutics, Inc., (“ITI”) a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today…
Read More
The SBA’s PPP: How to Prepare for a Potential Audit
Since the enactment of the CARES Act, the Small Business Administration and U.S. Department of the Treasury have continually updated the rules governing the…
Read More
BioHealth Innovation Entrepreneur-in-Residence Feedback Session – May 27th
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Sign up by…
Read More
Immunomic Therapeutics Founder and CEO Bill Hearl RETURNS to BioTalk after completing a new $61.3 million raise.
He joins BioTalk host Rich Bendis to discuss their recent successes in funding, research, and their growth in the BioHealth Capital Region Dr. William…
Read More
THE BIOHEALTH CAPITAL REGION (BHCR) IS CRITICAL TO AMERICA AND THE WORLD IN SOLVING HEALTHCARE’S CHALLENGES
Today we hear phrases such as “In these difficult times” to highlight the challenges of the world with COVID-19 which is on all of…
Read More
Venture vs. The Virus: The Life Science/Healthcare Outlook for Fundraising During a Pandemic · BioBuzz (May 13)
I know what you’re thinking…it’s hard enough to raise venture capital for life science/healthcare startups in normal times, but throw a global pandemic and…
Read More
Venture vs. The Virus: The Life Science/Healthcare Outlook for Fundraising During a Pandemic · BioBuzz (May 13)
I know what you’re thinking…it’s hard enough to raise venture capital for life science/healthcare startups in normal times, but throw a global pandemic and…
Read More
UMB-born medical device company Breethe acquired by Abiomed – Technical.ly Baltimore
Breethe, the medical device company founded by renowned University of Maryland School of Medicine surgeon and professor Dr. Bartley Griffith, has been acquired by…
Read More
Resources to Accelerate COVID Funding Applications
Are you working with a technology that may be valuable to the fight against COVID-19? BHI has expanded its federal funding assistance program to…
Read More
“Bayh-Dole 40 and the Coronavirus Crisis” Video Webinar RECAP (Webinar occurred on 4/23)
On April 23, 2020, the Bayh-Dole 40 Coalition and the Information Technology and Innovation Foundation co-hosted a video webinar on the critical role that…
Read More
Maryland plays an outsized role in worldwide hunt for a coronavirus vaccine – The Washington Post
As the world anxiously awaits a coronavirus vaccine, a Maryland biotechnology company already has signed deals to do initial production of three candidates. If one of…
Read More
Emergent BioSolution’s deal with Johnson & Johnson has geopolitical significance – Washington Business Journal
Emergent BioSolutions Inc.’s $135 million deal struck late last month to manufacture Johnson & Johnson’s Covid-19 vaccine candidate isn’t just a big financial win…
Read More
Maryland Industrial Partnerships (MIPS)
Grants for Technology Product Development Market-driven new technology and innovation leads to new products and new jobs. Creating jobs in innovative Maryland companies is…
Read More